4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-12-001314
Executive VP, CMO acquired 65,380 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Youssoufian Hagop Executive VP, CMO | 2011-12-30 | Grant or award | +65,380 | 115,380 | D |
Loading xslF345X03/doc4.xml…